Serum calcium levels are associated with novel cardiometabolic risk factors in the population-based CoLaus study

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Guessous, Idris ^a,b   Bonny, Olivier ^c   Paccaud, Fred ^a   Mooser, Vincent ^d   Waeber, Gérard ^c   Vollenweider, Peter ^c   Bochud, Murielle ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CALCIUM; GAMMA GLUTAMYLTRANSFERASE; HOMOCYSTEINE; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN; URIC ACID;

ADULT; AGED; ARTICLE; BODY FAT; BODY MASS; CALCIUM BLOOD LEVEL; CARDIOMETABOLIC RISK; CAUCASIAN; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; OXIDATIVE STRESS; PARTICLE SIZE; POPULATION RESEARCH; RISK; RISK FACTOR; SWITZERLAND; URIC ACID BLOOD LEVEL; BLOOD; CARDIOVASCULAR DISEASE; METABOLIC DISORDER; MIDDLE AGED;

ADULT; BODY MASS INDEX; CALCIUM; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; METABOLIC DISEASES; MIDDLE AGED; RISK FACTORS; SWITZERLAND;

EID: 79955380889     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018865     Document Type: Article

References (47)

1. Jorde R, Sundsfjord J, Fitzgerald P, Bonaa KH, (1999) Serum calcium and cardiovascular risk factors and diseases: the Tromso study. Hypertension 34: 484-490.
2. Wareham NJ, Byrne CD, Carr C, Day NE, Boucher BJ, et al. (1997) Glucose intolerance is associated with altered calcium homeostasis: a possible link between increased serum calcium concentration and cardiovascular disease mortality. Metabolism 46: 1171-1177.
3. Lind L, Jakobsson S, Lithell H, Wengle B, Ljunghall S, (1988) Relation of serum calcium concentration to metabolic risk factors for cardiovascular disease. BMJ 297: 960-963.
4. De Bacquer D, De Henauw S, De Backer G, Kornitzer M, (1994) Epidemiological evidence for an association between serum calcium and serum lipids. Atherosclerosis 108: 193-200.
5. Ahlstrom T, Hagstrom E, Larsson A, Rudberg C, Lind L, et al. (2009) Correlation between plasma calcium, parathyroid hormone (PTH) and the metabolic syndrome (MetS) in a community-based cohort of men and women. Clin Endocrinol (Oxf) 71: 673-678.
6. Leyva F, Godsland IF, Ghatei M, Proudler AJ, Aldis S, et al. (1998) Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol 18: 928-933.
7. Barter PJ, Ballantyne CM, Carmena R, Castro Cabezas M, Chapman MJ, et al. (2006) Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med 259: 247-258.
8. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, et al. (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116: 1784-1792.
9. Lippi G, Montagnana M, Franchini M, Favaloro EJ, Targher G, (2008) The paradoxical relationship between serum uric acid and cardiovascular disease. Clin Chim Acta 392: 1-7.
10. Guven A, Inanc F, Kilinc M, Ekerbicer H, (2005) Plasma homocysteine and lipoprotein (a) levels in Turkish patients with metabolic syndrome. Heart Vessels 20: 290-295.
11. Giral P, Ratziu V, Couvert P, Carrie A, Kontush A, et al. (2010) Plasma bilirubin and gamma-glutamyltransferase activity are inversely related in dyslipidemic patients with metabolic syndrome: relevance to oxidative stress. Atherosclerosis 210: 607-613.
12. Okamoto Y, (2011) Adiponectin provides cardiovascular protection in metabolic syndrome. Cardiol Res Pract 2011: 313179.
13. Kajikawa Y, Ikeda M, Takemoto S, Tomoda J, Ohmaru N, et al. (2011) Association of circulating levels of leptin and adiponectin with metabolic syndrome and coronary heart disease in patients with various coronary risk factors. Int Heart J 52: 17-22.
14. Onat A, Can G, Hergenc G, Yazici M, Karabulut A, et al. (2007) Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation. Int J Obes (Lond) 31: 1119-1125.
15. Vonbank A, Saely CH, Rein P, Beer S, Breuss J, et al. (2011) Insulin Resistance is Associated with the Metabolic Syndrome and is Not Directly Linked to Coronary Artery Disease. Clin Chim Acta.
16. Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, et al. (2010) High-sensitivity C-reactive protein and gamma-glutamyl transferase levels are synergistically associated with metabolic syndrome in community-dwelling persons. Cardiovasc Diabetol 9: 87.
17. Kim ES, Kwon HS, Ahn CW, Lim DJ, Shin JA, et al. (2010) Serum uric acid level is associated with metabolic syndrome and microalbuminuria in Korean patients with type 2 diabetes mellitus. J Diabetes Complications.
18. Bjorck J, Hellgren M, Rastam L, Lindblad U, (2006) Associations between serum insulin and homocysteine in a Swedish population-a potential link between the metabolic syndrome and hyperhomocysteinemia: the Skaraborg project. Metabolism 55: 1007-1013.
19. Firmann M, Mayor V, Vidal PM, Bochud M, Pecoud A, et al. (2008) The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord 8: 6.
20. Lean ME, Han TS, Morrison CE, (1995) Waist circumference as a measure for indicating need for weight management. BMJ 311: 158-161.
21. Jebb SA, Siervo M, Murgatroyd PR, Evans S, Fruhbeck G, et al. (2007) Validity of the leg-to-leg bioimpedance to estimate changes in body fat during weight loss and regain in overweight women: a comparison with multi-compartment models. Int J Obes (Lond) 31: 756-762.
22. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, et al. (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139: 137-147.
23. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, et al. (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752.
24. Hagstrom E, Hellman P, Lundgren E, Lind L, Arnlov J, (2007) Serum calcium is independently associated with insulin sensitivity measured with euglycaemic-hyperinsulinaemic clamp in a community-based cohort. Diabetologia 50: 317-324.
25. Duh QY, Morris RC, Arnaud CD, Clark OH, (1986) Decrease in serum uric acid level following parathyroidectomy in patients with primary hyperparathyroidism. World J Surg 10: 729-736.
26. Ljunghall S, Akerstrom G, (1982) Urate metabolism in primary hyperparathyroidism. Urol Int 37: 73-78.
27. Lind L, Skarfors E, Berglund L, Lithell H, Ljunghall S, (1997) Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. J Clin Epidemiol 50: 967-973.
28. Sun G, Vasdev S, Martin GR, Gadag V, Zhang H, (2005) Altered calcium homeostasis is correlated with abnormalities of fasting serum glucose, insulin resistance, and beta-cell function in the Newfoundland population. Diabetes 54: 3336-3339.
29. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, et al. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20: 1595-1599.
30. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, et al. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86: 1930-1935.
31. Godsland IF, Rosankiewicz JR, Proudler AJ, Johnston DG, (2001) Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men. J Clin Endocrinol Metab 86: 719-723.
32. Zhang D, Jiang X, Fang P, Yan Y, Song J, et al. (2009) Hyperhomocysteinemia promotes inflammatory monocyte generation and accelerates atherosclerosis in transgenic cystathionine beta-synthase-deficient mice. Circulation 120: 1893-1902.
33. Yilmaz N, Eren E, (2009) Homocysteine oxidative stress and relation to bone mineral density in post-menopausal osteoporosis. Aging Clin Exp Res 21: 353-357.
34. Altindag O, Erel O, Soran N, Celik H, Selek S, (2008) Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis. Rheumatol Int 28: 317-321.
35. Dawson J, Quinn T, Walters M, (2007) Uric acid reduction: a new paradigm in the management of cardiovascular risk? Curr Med Chem 14: 1879-1886.
36. Newaz MA, Adeeb NN, Muslim N, Razak TA, Htut NN, (1996) Uric acid, xanthine oxidase and other risk factors of hypertension in normotensive subjects. Clin Exp Hypertens 18: 1035-1050.
37. Zaidi A, Michaelis ML, (1999) Effects of reactive oxygen species on brain synaptic plasma membrane Ca(2+)-ATPase. Free Radic Biol Med 27: 810-821.
38. Huschenbett J, Zaidi A, Michaelis ML, (1998) Sensitivity of the synaptic membrane Na+/Ca2+ exchanger and the expressed NCX1 isoform to reactive oxygen species. Biochim Biophys Acta 1374: 34-46.
39. Hoenderop JG, Nilius B, Bindels RJ, (2005) Calcium absorption across epithelia. Physiol Rev 85: 373-422.
40. Goldberg DM, (1980) Structural, functional, and clinical aspects of gamma-glutamyltransferase. CRC Crit Rev Clin Lab Sci 12: 1-58.
41. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, et al. (2005) Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 112: 2130-2137.
42. Giral P, Jacob N, Dourmap C, Hansel B, Carrie A, et al. (2008) Elevated gamma-glutamyltransferase activity and perturbed thiol profile are associated with features of metabolic syndrome. Arterioscler Thromb Vasc Biol 28: 587-593.
43. Onat A, Hergenc G, Karabulut A, Turkmen S, Dogan Y, et al. (2006) Serum gamma glutamyltransferase as a marker of metabolic syndrome and coronary disease likelihood in nondiabetic middle-aged and elderly adults. Prev Med 43: 136-139.
44. Andre P, Balkau B, Born C, Charles MA, Eschwege E, (2006) Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort. Diabetologia 49: 2599-2603.
45. Wannamethee G, Ebrahim S, Shaper AG, (1995) Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 142: 699-708.
46. Ermak G, Davies KJ, (2002) Calcium and oxidative stress: from cell signaling to cell death. Mol Immunol 38: 713-721.
47. Lee CT, Tsai YC, Ng HY, Su Y, Lee WC, et al. (2009) Association between C-reactive protein and biomarkers of bone and mineral metabolism in chronic hemodialysis patients: a cross-sectional study. J Ren Nutr 19: 220-227.